Tolerant B lymphocytes acquire resistance to fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded

被引:54
作者
Foote, LC
Marshak-Rothstein, A
Rothstein, TL
机构
[1] Boston Univ, Med Ctr, Dept Microbiol, Boston, MA 02118 USA
[2] Boston Univ, Med Ctr, Dept Pathol, Boston, MA 02118 USA
[3] Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA
[4] Boston Univ, Med Ctr, Evans Mem Dept Clin Res, Boston, MA 02118 USA
关键词
D O I
10.1084/jem.187.6.847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to Fas-mediated apoptosis in nontolerant B cells is regulated in a receptor-specific fashion. To explore the regulation of Fas killing in tolerant, autoreactive B cells, mice doubly transgenic for hen egg lysozyme (HEL)-specific B cell receptors and soluble HEL were examined. Engagement of CD40 led to enhanced Fas expression and acquisition of sensitivity to Fas-mediated apoptosis in tolerant B cells, similar to that observed in nontolerant, receptor transgenic B cells. Engagement of surface immunoglobulin by specific (HEL) antigen failed to induce Fas resistance in tolerant B cells, in contrast to its effect on nontolerant B cells; however, cross-linking of biotinylated HEL with streptavidin induced similar levels of Fas resistance in tolerant and nontolerant B cells, which approximated the degree of Fas resistance produced by anti-Ig. Unlike surface Ig (sig) engagement, physiological engagement of IL-4 receptors produced similar levels of Fas resistance in tolerant and nontolerant B cells. Thus, tolerant B cells differ from nontolerant B cells in the diminished capacity of surface immunoglobulin engagement to produce Fas resistance; however, tolerant B cells can be induced to become resistant to Fas-mediated apoptosis by IL-4 or by higher order cross-linking of sIg receptors.
引用
收藏
页码:847 / 853
页数:7
相关论文
共 35 条
[1]   Enhanced and accelerated lymphoproliferation in Fas-null mice [J].
Adachi, M ;
Suematsu, S ;
Suda, T ;
Watanabe, D ;
Fukuyama, H ;
Ogasawara, J ;
Tanaka, T ;
Yoshida, N ;
Nagata, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2131-2136
[2]   HOMOLOGY OF THE NH2-TERMINAL AMINO-ACID SEQUENCES OF THE HEAVY AND LIGHT-CHAINS OF HUMAN MONOCLONAL LUPUS AUTOANTIBODIES CONTAINING THE DOMINANT 16/6 IDIOTYPE [J].
ATKINSON, PM ;
LAMPMAN, GW ;
FURIE, BC ;
NAPARSTEK, Y ;
SCHWARTZ, RS ;
STOLLAR, BD ;
FURIE, B .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) :1138-1143
[3]  
BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
[4]  
CARROLL P, 1985, J IMMUNOL, V135, P1086
[5]  
CHEN SZ, 1990, BIOTECHNIQUES, V8, P32
[6]   IMMUNOGLOBULIN SIGNAL-TRANSDUCTION GUIDES THE SPECIFICITY OF B-CELL T-CELL-INTERACTIONS AND IS BLOCKED IN TOLERANT SELF-REACTIVE B-CELLS [J].
COOKE, MP ;
HEATH, AW ;
SHOKAT, KM ;
ZENG, YJ ;
FINKELMAN, FD ;
LINSLEY, PS ;
HOWARD, M ;
GOODNOW, CC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :425-438
[7]  
DIPIRO JT, 1995, ARCH SURG-CHICAGO, V130, P1159
[8]   POLYSPECIFICITY OF HUMAN MONOCLONAL-ANTIBODIES REACTIVE WITH MYCOBACTERIUM-LEPRAE, MITOCHONDRIA, SSDNA, CYTOSKELETAL PROTEINS, AND THE ACETYLCHOLINE-RECEPTOR [J].
DUGGAN, DB ;
MACKWORTHYOUNG, C ;
KARILEFVERT, A ;
ANDRESCHWARTZ, J ;
MUDD, D ;
MCADAM, KPWJ ;
SCHWARTZ, RS .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (03) :327-340
[9]  
ERIS JM, 1994, P NATL ACAD SCI USA, V92, P99
[10]  
Foote LC, 1996, J IMMUNOL, V157, P2749